UnitedHealth’s first-quarter report will offer a window into Change cyberattack costs

UnitedHealth’s first-quarter report will offer a window into Change cyberattack costs


Omar Marques | Lightrocket | Getty Images

UnitedHealth Group’s first-quarter earnings call will mark the health care giant’s first major public comments since a cyberattack on its Change Healthcare billing and payments subsidiary in February, which has led to the largest disruption in U.S. health care since the Covid pandemic.

“Everybody looks to United as the bellwether of all of healthcare services. This will be different,” said Lisa Gill, managing director and health care analyst at JPMorgan.   

The data breach at the Change Healthcare unit forced the firm to take down its massive billing and payment processing service. While the company has restored services for pharmacies, the outage has continued to disrupt operations for health care providers across the country.

Change Healthcare is a subsidiary of UnitedHealth’s sprawling Optum division, which includes 90,000 doctors under the Optum Care unit and one of the nation’s largest pharmacy benefits managers, OptumRx.

Analysts will be looking for how the company accounts for the costs associated with the cyberattack as well as the impact of the outage on other operations within Optum’s businesses.

“We will be very interested in the charge that they’re going to be incurring … in terms of how they’re estimating either lost revenue or additional expenses,” said Scott Fidel, managing director and health care analyst at Stephens.

UnitedHealth says it has provided $4.7 billion in no-interest loans to providers, though the American Medical Association says more than half of physician groups surveyed in early April said they’d had to use personal loans to maintain operations.

One such physician, Nashville dermatologist James Allred, said he’s had to take out loans to keep his practice, Wellskin Dermatology & Aesthetics, afloat because he’s been unable to get claims processed and paid by private health insurers. The last six weeks have forced to him to give up on plans to expand his practice this year.

“For one single hack to disrupt the entire American healthcare industry… brings a lot of questions about how healthy is it, from a system standpoint, to have this massive consolidation?” Allred said.

Larger providers, like home infusion services firm Option Care Health, have also warned that the outage could impact their quarterly results.

Medicare Advantage uncertainty  

On the health insurance side, the timing of the Change hack has increased uncertainty for UnitedHealthcare and rivals like Humana, CVS Health’s Aetna and Elevance, which reports its quarterly results on Thursday.

All of the Medicare Advantage insurers reported higher-than-expected medical utilization rates among seniors during the fourth quarter.

With the Change outage taking place mid-way through the first quarter, it has likely made it more difficult for insurers to track medical utilization costs in real time. JPMorgan’s Gill expects most will report adjusted or estimated numbers.

“We’re going to have to wait for the second quarter to really get a better idea as to what’s happening with medical cost trend for United and most likely for the industry,” said Gill.

The delayed outlook on medical costs will also raise the stakes for the health insurers as they prepare 2025 Medicare Plan bids, which are due in early June. It comes after disappointing government payment rate increases for 2025, announced earlier this month, which are expected to pose a profit headwind.  

“We’ve got elevated cost trends. We’ve got still… a pretty competitive market,” said Gill. “So, they have to work through that.”



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More